Chemical inhibitors of AI324046 encompass a variety of compounds that target specific kinases and enzymes responsible for the phosphorylation and regulation of the protein's activity. Staurosporine is a broad-spectrum kinase inhibitor which binds to ATP-binding sites of various protein kinases, thus preventing the phosphorylation of AI324046, which is essential for its activity. This inhibition is direct, as phosphorylation is a post-translational modification critical to AI324046's function. Similarly, Bisindolylmaleimide I targets protein kinase C, which plays a pivotal role in the phosphorylation cascade that activates AI324046. By hindering the activity of protein kinase C, Bisindolylmaleimide I effectively reduces the phosphorylation and subsequent activity of AI324046. Another kinase inhibitor, KN-93, selectively inhibits Ca2+/calmodulin-dependent protein kinase II, which is likely involved in the phosphorylation of AI324046, thereby directly reducing its activity.
In parallel, PD 98059 and U0126 both target MEK enzymes within the MAPK/ERK pathway, which is known to phosphorylate AI324046. By inhibiting MEK, both PD 98059 and U0126 prevent the activation of the MAPK/ERK pathway, leading to the direct reduction of AI324046 phosphorylation and activity. LY294002 and Wortmannin are PI3K inhibitors that suppress the PI3K/AKT signaling pathway, which is upstream of various protein phosphorylations, including potentially that of AI324046. This suppression results in a decrease in AI324046 activity due to reduced phosphorylation. Rapamycin exerts its inhibitory effect by binding to mTOR, a key regulator in the mTOR signaling pathway, which is responsible for AI324046 activation. The inhibition of mTOR by Rapamycin leads to a direct decrease in AI324046 activity. PP2, by inhibiting Src family kinases, prevents the phosphorylation of substrates such as AI324046, thereby directly reducing the protein's activity. SP600125 and SB203580 inhibit the JNK and p38 MAP kinase, respectively, both of which are part of the MAPK pathway and are involved in the phosphorylation that regulates AI324046 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases which are responsible for phosphorylation of AI324046, thus directly hindering the protein's phosphorylation-dependent functional activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits protein kinase C which is involved in the phosphorylation of AI324046, leading to a direct decrease in the protein's phosphorylation and subsequent activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits Ca2+/calmodulin-dependent protein kinase II, a kinase that could be directly responsible for the phosphorylation and activation of AI324046, thereby inhibiting its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 inhibits MEK, which is part of the MAPK/ERK pathway, a pathway known to phosphorylate and regulate AI324046, resulting in direct inhibition of AI324046's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which is upstream of AKT signaling, a pathway that can regulate the phosphorylation state of AI324046, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, similar to LY294002, and thereby inhibits downstream AKT signaling that is responsible for regulating AI324046 activity through phosphorylation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the mTOR signaling pathway that can directly regulate AI324046 through phosphorylation and activation, thereby inhibiting its function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 inhibits Src family kinases, which may directly phosphorylate and regulate AI324046, leading to inhibition of its functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is involved in phosphorylation of proteins within the MAPK pathway, potentially including AI324046, leading to direct inhibition of its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which may directly phosphorylate AI324046, resulting in inhibition of AI324046's functional activity. | ||||||